153 related articles for article (PubMed ID: 21245368)
1. Gene targeting through o-methylated catecholamine metabolite patterns.
Shine B
Clin Chem; 2011 Mar; 57(3):361-2. PubMed ID: 21245368
[No Abstract] [Full Text] [Related]
2. Pheochromocytoma and paraganglioma: recent progress and new vistas for improved patient care.
Eisenhofer G; Schott M; Bornstein S
Horm Metab Res; 2012 May; 44(5):325-7. PubMed ID: 22566193
[No Abstract] [Full Text] [Related]
3. Localizing value of catecholamine profile in patients with adrenal or ectopic pheochromocytoma.
Azizi M; Day M; Plouin PF
Am J Hypertens; 1994 Jan; 7(1):110-1. PubMed ID: 8136104
[No Abstract] [Full Text] [Related]
4. Somatic mutations in H-RAS in sporadic pheochromocytoma and paraganglioma identified by exome sequencing.
Crona J; Delgado Verdugo A; Maharjan R; Stålberg P; Granberg D; Hellman P; Björklund P
J Clin Endocrinol Metab; 2013 Jul; 98(7):E1266-71. PubMed ID: 23640968
[TBL] [Abstract][Full Text] [Related]
5. Pheochromocytoma: a review.
Tsirlin A; Oo Y; Sharma R; Kansara A; Gliwa A; Banerji MA
Maturitas; 2014 Mar; 77(3):229-38. PubMed ID: 24472290
[TBL] [Abstract][Full Text] [Related]
6. Pheochromocytoma: recommendations for clinical practice from the First International Symposium. October 2005.
Pacak K; Eisenhofer G; Ahlman H; Bornstein SR; Gimenez-Roqueplo AP; Grossman AB; Kimura N; Mannelli M; McNicol AM; Tischler AS;
Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):92-102. PubMed ID: 17237836
[TBL] [Abstract][Full Text] [Related]
7. Pheochromocytoma: rediscovery as a catecholamine-metabolizing tumor.
Eisenhofer G; Goldstein DS; Kopin IJ; Crout JR
Endocr Pathol; 2003; 14(3):193-212. PubMed ID: 14586065
[TBL] [Abstract][Full Text] [Related]
8. Plasma free catecholamine level during hemopurification in a case of pheochromocytoma.
Hiramatsu K; Suzuki T; Arimori S; Hida M; Satoh T
Intern Med; 1992 Mar; 31(3):438-40. PubMed ID: 1611202
[TBL] [Abstract][Full Text] [Related]
9. Pheochromocytoma and paraganglioma.
Kantorovich V; Pacak K
Prog Brain Res; 2010; 182():343-73. PubMed ID: 20541673
[TBL] [Abstract][Full Text] [Related]
10. Genotype-Dependent Brown Adipose Tissue Activation in Patients With Pheochromocytoma and Paraganglioma.
Puar T; van Berkel A; Gotthardt M; Havekes B; Hermus AR; Lenders JW; van Marken Lichtenbelt WD; Xu Y; Brans B; Timmers HJ
J Clin Endocrinol Metab; 2016 Jan; 101(1):224-32. PubMed ID: 26574955
[TBL] [Abstract][Full Text] [Related]
11. Hereditary pheochromocytoma and paraganglioma.
Mazzaglia PJ
J Surg Oncol; 2012 Oct; 106(5):580-5. PubMed ID: 22648936
[TBL] [Abstract][Full Text] [Related]
12. Malignant pheochromocytomas and paragangliomas: molecular signaling pathways and emerging therapies.
Santarpia L; Habra MA; Jiménez C
Horm Metab Res; 2009 Sep; 41(9):680-6. PubMed ID: 19343618
[TBL] [Abstract][Full Text] [Related]
13. Energy and metabolic alterations in predisposition to pheochromocytomas and paragangliomas: the so-called Warburg (and more) effect, 15 years on.
Neumann HP; de Herder W
Endocr Relat Cancer; 2015 Aug; 22(4):E5-7. PubMed ID: 26273100
[No Abstract] [Full Text] [Related]
14. [The clinical significance of the determination of catecholamine catabolites in neoplasms].
Käser H; Schweisguth O; Sellei K; Spengler GA
Helv Med Acta; 1963 Nov; 30(4):628-39. PubMed ID: 5878832
[No Abstract] [Full Text] [Related]
15. Pheochromocytoma and paraganglioma.
Meyer-Rochow GY; Sidhu SB
Cancer Treat Res; 2010; 153():135-62. PubMed ID: 19957224
[No Abstract] [Full Text] [Related]
16. Succinate-Dehydrogenase Deficient Paragangliomas/Pheochromocytomas: Genetics, Clinical Aspects and Mini- Review.
Rusyn L; Kohn B
Pediatr Endocrinol Rev; 2017 Mar; 14(3):312-325. PubMed ID: 28508602
[No Abstract] [Full Text] [Related]
17. Catecholamine metabolism in paraganglioma and pheochromocytoma: similar tumors in different sites?
Grouzmann E; Tschopp O; Triponez F; Matter M; Bilz S; Brändle M; Drechser T; Sigrist S; Zulewski H; Henzen C; Fischli S; Abid K
PLoS One; 2015; 10(5):e0125426. PubMed ID: 25946206
[TBL] [Abstract][Full Text] [Related]
18. Phaeochromocytoma and Paraganglioma.
Gunawardane PTK; Grossman A
Adv Exp Med Biol; 2017; 956():239-259. PubMed ID: 27888488
[TBL] [Abstract][Full Text] [Related]
19. Can cerebellin and renalase measurements contribute to the elimination of false positive results in pheochromocytoma and paraganglioma diagnoses?
Aydin S
Med Hypotheses; 2017 Sep; 107():64. PubMed ID: 28915965
[No Abstract] [Full Text] [Related]
20. Pheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatment.
Martucci VL; Pacak K
Curr Probl Cancer; 2014; 38(1):7-41. PubMed ID: 24636754
[No Abstract] [Full Text] [Related]
[Next] [New Search]